ArticleFrontiers in cardiovascular medicine2016

Glycemic Control with Ipragliflozin, a Novel Selective SGLT2 Inhibitor, Ameliorated Endothelial Dysfunction in Streptozotocin-Induced Diabetic Mouse.

Hotimah Masdan Salim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.